Past President European Brain Council
Dr Mary Baker, MBE, is Past President of the European Brain Council. Mary is Past President of the European Federation of Neurological Associations, Consultant to the World Health Organisation (WHO), Chair of the Working Group on Parkinson’s Disease, a member of the Strategic Advisory Board of the Human Brain Project, and a member of the Commission’s CONNECT Advisory Forum. Academic appointments include Associate Membership of the Health Services Research Unit, University of Oxford and Visiting Fellow within the London School of Economics (LSE) Health Centre.
An Honorary Doctorate from the University of Surrey was conferred upon Mary in 2003 and an Honorary Doctor of Science degree was awarded by Aston University in July 2013. In 2009 she received the prestigious British Neuroscience Association Award for Outstanding Contribution to British Neuroscience and for Public Service. In 2014, Mary received the Dana/EDAB Lifetime Achievement Award for Outreach on Behalf of Brain Research. Mary graduated from the University of Leeds with a BA Hons in Sociology and Political Theory.
Director, Lung Screening Program, Mount Sinai
Dr. Claudia Henschke is a Professor of Radiology and heads the Lung and Cardiac Screening Program at the Mount Sinai Medical Center. A pioneer and leading expert in the field of diagnostic radiology, Dr. Henschke has long believed that smokers and former smokers should consider being tested with low-dose CT scans to detect lung cancer when a tumor is still small enough to be cured. Dr. Henschke has more than 20 years of clinical and research experience in this area and, since 1993, has led city, state, national, and international projects that have resulted in the diagnosis of some 800 lung cancers. She and her team have created a protocol that has set an international standard for performing low-dose CT scans and managing findings which require additional testing.
Her team has developed techniques that provide 3D growth assessment of a lesion. Using these techniques lesion growth can be measured and compared to the rate of growth seen in malignant tumors. This can help distinguish those lesions that are benign from those that are malignant. Dr. Henschke heads the International Early Lung Cancer Action Program (I-ELCAP) which is an international collaborative group consisting of experts on lung cancer related issues. More than 60 sites in the world have participated in this research program.
Dr. Henschke received a M.S. in mathematical statistics from Southern Methodist University and her PhD in mathematical statistics and computer science in 1969 from the University of Georgia. She was awarded her medical degree from Howard University in 1977. She completed her radiology residency at the Peter Bent Brigham Hospital, Harvard Medical School, and in 1981 was named to the faculty of the Department of Radiology at Harvard Medical School. Dr. Henschke was a Professor of Radiology at Weill Cornell Medical College before joining Mount Sinai.
Member of the European Parliament
In 1982 Lambert van Nistelrooij joined the Brabant States Group of the CDA. Between 1991 and 2003, he was a member of the Deputies of the North-Brabant Province where he among others was responsible for internationalisation.
Van Nistelrooij later became a member of the Dutch delegation to the Committee of the Regions in Brussels and Treasurer of the House of Dutch Provinces in Brussels. He was also Vice President of the Assembly of European Regions for some time. In 2004 Lambert van Nistelrooij got elected as a Member of the European Parliament and he was re-elected in 2009 and 2014. He is a member of the EP Committee on Regional Development and a substitute member of the EP committee on Internal Market.
During his second mandate he was also engaged in energy and telecommunications in his role as a substitute member of the EP Committee on Industry, Research and Energy. Lambert van Nistelrooij also is the European Parliament Rapporteur and Negotiator for the European Structural Funds and the European Investment Fund (2014–2020).
LUCE (Lung Cancer Europe)
I am currently the President of Lung Cancer in Europe (LuCE) and member of the International Association for the Study of Lung Cancer (IASLC) Advocacy Committee since 2013. In 2007 I joined Women Against Lung Cancer in Europe (WALCE), a lung cancer patient organization based in Italy and I network for it at both national and international levels. Since the beginning I have been working as a patient advocate with a particular focus on lung cancer awareness initiatives (the November Lung Cancer Awareness, antismoking, symptom and early detection campaigns) and patient support activities in Italy and abroad. My experience in the advocacy field happened by chance. I am neither a patient nor a caregiver, but as I am involved in the field on a daily basis, it has been my choice to actively promote early and equal access to treatment and care and improved quality of life for lung cancer patients in Europe and worldwide.
University of Liverpool
Professor John Field, PhD, FRCPath has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool. He is a Visiting Professor at University College London, holds the post of Director of Research of the Roy Castle Lung Cancer Research Programme. He is the CI for the UK Lung Cancer Screening Trial (UKLS), Chair of the EU-US Spiral CT collaborative group, Chair (2011- ) IASLC Early Detection and Prevention Committee. Presented with the IASLC Joseph Cullen Award at the WCLC 2011, in recognition of lifetime scientific achievements in lung cancer prevention research.
He is the principle investigator of the Liverpool Lung Project, a 10 year molecular- epidemiological study into the early detection of lung cancer, funded by the Roy Castel Lung Cancer Foundation. He is also PI on the large EU Early Lung Cancer study funded by the Commission. Both of these trials form part of the NCRI Lung Cancer clinical studies group’s portfolio. He is a member of the NCRI Lung Cancer Clinical Study Group and Chairs the Lung Cancer Translational Sub-group. He is also heavily involved in the identification of molecular diagnostic markers in lung and head & neck cancer and has led the team searching for the familial oesophageal cancer gene (TOC) over the past decade, His research funding has been provided mainly by the RCF, NWCRF, MRC, CRC, EU and HTA.
Professor Field is the author of over 200 international (peer reviewed) papers in his area of expertise and has given more than 270 presentations at medical and scientific conferences around the world.
Senior Vice President and Regional President (EMEAC), MSD Oncology
Deepak took on this new role in January 2014 and is responsible for developing MSD & Merck’s oncology capabilities across Europe Prior to this role, Deepak was SVP and Managing Director of MSD UK and Ireland from 2009-2013, a role which included the integration of MSD with Schering-Plough.
Alongside his role as UK Managing Director, Deepak played an active role in pharmaceutical industry affairs. He held the position of President of the Association of the British Pharmaceutical Industry (ABPI) between April 2012 and April 2014 and oversaw the pricing and reimbursement negotiations with the UK government during his tenure. Prior to this, he was Chair of the American Pharmaceutical Group (APG).
Deepak began his career at Merck in 1988 in field sales and progressed to positions of increasing responsibility within the U.S. and Worldwide Human Health Division. His career has included roles as Vice President and General Manager of Merck/Schering-Plough Pharmaceuticals. He managed all aspects of the U.S. Merck/Schering-Plough Joint Venture and was responsible for the U.S. marketing and sales for the two cardiovascular products jointly marketed by the two companies. After the announcement of plans to merge with Schering-Plough (March 2009), Mr Khanna also led the U.S. integration planning efforts.
In 1996, Deepak joined the Worldwide Human Health Marketing Division working with rheumatology products; he later assumed responsibility for the marketing planning activities to support early stage central nervous system products. Deepak rejoined the U.S. Human Health Division in 2001 and assumed leadership responsibilities of the Migraine Franchise Business Group. In January 2003, he was promoted to Vice President of the Atherosclerosis Franchise Business Group.
Humanitas Research Hospital, Milan
Dr. Giulia Veronesi is specialist in General Surgery (2000 at University of Milan) and in Thoracic Surgery (2006 at University of Modena). She trained in thoracic surgery in Milan, at the European Institute of Oncology, and in Paris at the Institute Mutualiste Montsouris. She was visiting physician in New York at Cornell University, Mount Sinai Hospital and Memorial Sloan Kattering Cancer Center.
She was chief of prevention and early Detection at the Thoracic Surgery Division Unit of the European Institute of Oncology from 2000 to 2015. At present she is chief of the Robotic Thoracic Surgery Unit at the Division of Thoracic and General Surgery at Humanitas Research Hospital, Rozzano, Milan.
Since 2006 she developed a program of robotic surgery for thoracic diseases and performed more than 270 robotic surgical procedures at European Institute of Oncology and Humanitas Research Hospital. She is proctor of robotic surgery in Geneve Huniversity Hospital and in different Italian centers.
Since 2004 she has led one of the largest European lung cancer screening programs (the COSMOS 1 and 2) using low dose Computer Thomography and molecular markers in high risk individuals. She is Principal investigator of different NCI-supported trials focused mainly on lung cancer chemoprevention including the ongoing randomized double-blind phase II cancer prevention trial comparing daily aspirin with placebo in persons with sub-solid nodules on LDCT.
She is founding member of the Clinical Robotic Surgical Association (CRSA) and member of the Prevention/early Detection Committee of the International Association on Study of Lung Cancer. She is also active member of the European Society of Medical Oncology and faculty member of European Society of Thoracic Surgery (ESTS). She is associate editor at Frontiers of Oncology, ecancer medical journal and Lung cancer. She is reviewer for Ann Internal Medicine, American Journal of Respiratory and Critical Care Medicine.
She has been an invited speaker at more than 80 national and international conferences in particular as expert in the field of lung cancer prevention, lung cancer early detection and robotic minimally invasive thoracic surgery.
She is first author or coauthor of 159 papers on international peer reviewed journals and authors of 8 book chapters with an HI of 29 and IF of 568.
Institute of Public Health, Slovenia
Dr. Tit Albreht, M.D. (1961), Slovenian, Ph.D. in Health Services Research at the University of Amsterdam, Head of the Centre for Health Care at the National Institute of Public Health of Slovenia, A senior researcher in the field of health services research, health policy and health systems research, member of the Scientific Committee of EUPHA, president of the Slovenian Preventive Medicine Society, member of the Health Council of the Ministry of Health of Slovenia.
He acts as a reviewer of several scientific journals and of projects submitted for financing to the European Commission. From 2011 to 2014 he was a work package leader of the Work Package in the Joint Action EPAAC – European Partnership for Action Against Cancer. This process resulted in the European Guide on National Cancer Control Programmes. Since 2014, he is the coordinator of the Joint Action Cancon (Cancer Control), an EU co-financed project dedicated to informing the development of cancer policies at the EU and Member State levels. He is an Associate Professor of Public Health at the Medical Faculty of Ljubljana, Slovenia and teaching public health and epidemiology at the Medical Faculty of Maribor and at the University of Primorska.
Member of the European Parliament
Marian is an Independent MEP representing the 15 counties of the Midlands-North-West constituency in the European Parliament. Marian is a full member and ALDE Coordinator of the Employment and Social Affairs Committee, a substitute member on the Economic and Monetary Affairs Committee and a substitute member on the Petitions Committee.
As well as her legislative work Marian has a deep interest in Social and Public Health issues. She is Chair and founding member of both the Carers Interest Group and the Volunteering Interest Group and is also Vice Chair of the Cervical Cancer Group, Mental Health Group, Epilepsy Support Group, Human Dignity Working Group and Complementary and Alternative Medicine Group. She is a member of the MEP Heart Group, LGBTI Intergroup and MEPs against Cancer Group, the Intergroup on Ageing and Solidarity between Generations and the Social Economy Intergroup.
In 2011 in the MEP of the Year Awards Marian won the “Outstanding Achievement Award’ in recognition of her work in promoting the interests of volunteers and volunteering in the European Union. In 2012, she won the MEP of the Year award for her work in the area of Employment & Social Affairs.
Member of the European Parliament
Born in 1978 in Drobeta Turnu Severin, Romania, Cristian Busoi has a PhD in Public Health and Health Management. He graduated in medicine at the “Carol Davila” University in Bucharest, in law at the Titu Maiorescu University in Bucharest, and in diplomacy at the Romanian Diplomatic Institute in Bucharest. His political career started in 1996 when, as a young student, he became a member of the National Liberal Party. Eight years later, he entered the Romanian Parliament as Member of the Committee for Health and Family and in 2013 became President of the National Health Insurance.
His dedication in the Romanian Parliament convinced electors to vote him in 2007 as their representative in the European Parliament. He is a Member of the Committee on the Environment, Public Health and Food Safety, the Delegation to the EU-Ukraine and the Euronest Delegation. He is also a substitute Member on the Committee on Internal Market and Consumer Protection, the Delegation to the EU-Turkey Joint Parliamentary Committee and the Delegation for Relations with India.
MEP from 2007-2013 and since 2014.
King's College London
Tony Ng is the Richard Dimbleby Professor of Cancer Research, King’s College London and Professor of Molecular Oncology at University College London (UCL) Cancer Institute. He obtained his Medical Degree from University of Aberdeen, Scotland and PhD in Immunology from Medical College of St. Bartholomew’s Hospital, London. He has a mix of training/expertise in medicine, immunology, cancer cell biology, biochemistry, optical imaging and cell biophysics. Because of this mixed clinical/scientific background, he has adopted a multidisciplinary approach to understand cancer metastasis. His team is one of the few research groups in the UK & internationally, which can bridge the gap between Physics, Biology and Medicine, particularly in the field of translational cancer research. Professor Ng is currently the Principal Investigator and Coordinator for the KCL-UCL Comprehensive Cancer Imaging Centre.
He is also the Joint lead for The CRUK Lung Cancer Centre of Excellence Biomarkers theme. In addition, he leads the Tumour Immunology imaging project within the Breast Cancer Now Unit at KCL. The central driver for his engagements in these translational centres is to deliver a coherent & translationally oriented imaging-genomic-protein network combination approach, that his team has pioneered in developing over the recent years, to individualise cancer treatment. Most recently he has also expanded his imaging repertoire to the development of radionuclide imaging tracers against targeted molecules. For his multidisciplinary research contribution in cancer he was elected to Election to the Academy of Medical Sciences as a Fellow (FMedSci )in 2013. In this conference, he will share his thoughts on the use of the heterogeneous expression of exosomal HER receptors as well as their dimers as exploratory predictive markers for the use of ErbB/HER therapeutics, in conjunction with a novel HER3 radionuclide-based imaging tracer. The translational vision of combining whole body immuno-PET imaging of HER and exosomal receptor rewiring information, in correct stratification of patient treatment, will be discussed.
President Elect, European Respiratory Society
Dr Gaga is Medical Director at Athens Chest Hospital and also heads the Asthma Center and 7th Respiratory Medicine Department of the Hospital. She is involved in clinical research, particularly in severe asthma, in medical education and advocacy and in public health. She is the author of highly cited papers and has participated/lead international task forces. She has served as ERS School Director of Learning Resources, Secretary of the European Board of Accreditation in Pneumology (EBAP) and Secretary General of the ERS. She is currently President Elect of the ERS.
Chairman Guidelines Office Board European Association of Urology
Professor James N’Dow is Chairman of the EAU Guidelines Office Board. He is also Professor of Urological Surgery and Director of the Academic Urology Unit in the University of Aberdeen, Scotland, UK. He was appointed to the first Chair of Urology in Aberdeen’s history and was Co-ordinating Editor within the Cochrane Collaboration (Cochrane Incontinence Review Group) from 2008 -2012. His research interests are in Evidence synthesis and evidence based practice, large observational studies and multicentre randomised clinical trials with a competitive research grant income of over USD$ 30 million. Professor N’Dow is Co-Founder and Managing Director of the Urological CANcer charity (UCAN; www.ucanhelp.org.uk). UCAN has raised around USD$10 million so far and funded the opening of the first Urological Cancer Care Centre in Scotland, formally launched by the Health Minister in 2008. Professor N’Dow has a Urological Surgical practice in the University of Aberdeen Teaching Hospitals sub-specialising in penile and urethral surgery.
Head of Pneumology Department, Co-director of Lung Cancer Area, Clinica Universidad de Navarra
Graduated (1986) and was awarded his doctorate (1998) in Medicine and Surgery from the Complutense University of Madrid. He specialised in Internal Medicine at St. Luke's Hospital, a teaching centre in the Case Western University of Cleveland (USA).
He subspecialised in Pneumology and Intense Medicine at the New England Medicine Centre, in the Tufts University Hospital, in Boston (USA). He now works as the Head of the Pneumology Department at the Clinica Universidad de Navarra. Codirector of Lung Cancer Area.
His main research areas include the early detection of lung cancer and pulmonary emphysema, as well as the cause and effect relation between both diseases. He is the principal researcher on the I-ELCAP study, a multicentre international study for early detection of lung cancer using thoracic CT scans with a low radiation dosage, which began in 2008 and to date, have been used on more than 60,000 individuals.
Prof Francesco De Lorenzo is a colon cancer survivor, medical doctor, and professor of biochemistry. He has a rich experience in cancer advocacy being the co-founder, former Vice-President and current President of the European Cancer Patient Coalition. He is the founder and President of the Italian Association of Cancer Patients (AIMaC), Italy's Cancer Information Service (CIS), and the Italian Federation of Cancer Patients Organisations (FAVO). Francesco is also active in Italy's governmental network of cancer institutes (ACC), Italy's National Cancer Plan Committee, and Italy’s National Volunteer Observatory. Francesco is a member of the European Commission Expert Group on Cancer Control, a member of the European Society for Medical Oncology (ESMO) Cancer Patient Working Group, a founding member of the Elite Oncology Roundtable, and is the ECPC representative within the European Commission’s Joint Action on Cancer Control (CanCon). Francesco was also engaged in Italian politics as a Member of Parliament.
Member of the European Parliament
Born in 1948. Ljubljana. Elected MP 1990, 1992, 1996 and 2000. Prime Minister of the first democratically elected Slovenian Government (1990-1992). Deputy Prime Minister (1993-1994) and Minister of Foreign Affairs (1993-1994 and June-November 2000). Chairman of the Parliamentary Commission for European Affairs (1996). President of the Christian Democrats of Slovenia (1990-2000). Chairman of the Council of the New Slovenia-Christian People’s Party (2001-2005). Vice-President of the EUCD (1996-1999), Vice president of the European People's Party (2006-2009). Elected representative of the National Assembly to the European Convention and elected member of its presidency (2002-2003). Elected Member of the European Parliament since 2004. Head of the Slovenian Delegation in the EPP-ED (2004-2006). Personal Representative of the Chairman-in-Office of the OSCE for Central Asia (2004-2005). Co-chair of informal all-party forum "MEPs Against Cancer" and the WG on Health. MEP since 2004.
RGN, BNS, Grad Dip. Cancer Care, MSc Psycho-oncology
Information Development Manager at the Irish Cancer Society, Ireland. Special interests include lung cancer, psycho-oncology and cancer information development. Committee involvement includes National Executive Committee member of the Irish Association for Nurses in Oncology (IANO), Co-ordinator of the Irish Lung Cancer Nurses Group (ILCNG), Co-chair of the European Oncology Nursing Society (EONS) Advocacy working group and steering committee member of the Global Lung Cancer Coalition (GLCC).
Genetic Alliance UK
He came to Genetic Alliance UK over 20 years ago because He were excited by the challenge that new knowledge in genetics created - the idea that, for people affected by a genetic condition, yesterday's science fiction is tomorrow's clinical service improvement. Trying to transform these possibilities into positive outcomes whilst reducing the potential for abuse is an incredible challenge, and he feels incredibly privileged to work in this field. The fact that Genetic Alliance UK is now a respected and authoritative voice for patients and families is something about which he feels pride, and also a huge sense of responsibility. It is a challenge that excited him on the first day he became aware of the impact of genetic disorders and which continues to excite him today.
Member of the European Parliament
Miriam Dalli was elected to the European Parliament in May 2014. She currently sits as a full member on the Committee on the Environment, Public Health and Food Safety and on the Delegation for relations with the Maghreb countries. She is a substitute member on the Committee on Industry, Research and Energy, the Committee on Civil Liberties, Justice and Home Affairs, the Committee on Petitions and delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation.
Miriam Dalli successfully completed her Doctorate of Law at the University of Malta. With over 15 years of experience in the Communications sector Miriam Dalli established herself as one of the main television journalists in Malta. She worked as a journalist with ONE TV and was the first female news editors on the Islands heading a TV and Radio newsroom. She was Head of News on ONE TV and ONE Radio between 2005 and 2009.
Deputy Director General, Health and Consumers, European Commission
A graduate in chemistry and pharmaceutical technology, Mr. Seychell specialized in Chemical analysis. He has held important positions on several government boards and commissions in Malta, including the Food Safety Commission and the Pesticides Board. Mr Seychell occupied the post of Head of Directorate at the Malta Standards Authority between 2001 and 2006. He has been responsible for the implementation of a number of EU directives in the areas of risk assessment, food safety, chemicals and cosmetic products legislation, and has actively participated in negotiations on major technical proposals such as the new chemicals legislation, REACH, and in screening processes in the areas of free movement of goods, environment and agriculture during the process leading to Malta's accession to the EU. He held the post of Director of Environment in Malta between 2006 and 2011. As Director, he was responsible for a broad range of functions arising from the Maltese Environment Protection Act. He was appointed Deputy Director General for Health and Consumers at the European Commission in March 2011.
ENVI Chair, European Parliament
Born in 1963. Islands (Sardegna, Sicilia). Degree in "Agricultural Sciences", University of Catania, 1985. Agronomist, 1986. Internship study at University of Saragoza and INRA in Montpellier,1985. PhD in Agricultural Economics and Policy, 1988. Researcher,1989. Professor of "Economics and Management of agrofood enterprise" at University of Catania,1993. Assessor for Agriculture and Forestry of Sicilian Region, 2006-2009. Coordinator of several European research programs in Sicily (Sprint, Ritts, Fair, etc.)and author of numerous scientific papers on food and agricultural system.Member of the following scientific associations:SIDEA,SIEA,CeSET and EAAE. MEP since 2009.
Member of the European Parliament
Dr. Andrey Kovatchev is a Bulgarian politician, Member of the European Parliament, a federalist and Head of the Bulgarian Delegation in the EPP Group in the European Parliament. Dr. Andrey Kovatchev is a Chairman of the Union of the European Federalists in Bulgaria. Since 2011 he is a Vice-President of the Union of the European Federalist. In January 2012 he was elected vice-chair of AFET – Committee on Foreign Affairs of the European Parliament.
Andrey Kovatchev has a degree in Biology form Saarland University, Germany (1990–1995). Later he obtained a PhD in Biology from the same university. From 2007 Andrey Kovatchev is a Vice- chairman of the Committee on Foreign Policy and European Affairs and Vice – International Secretary of political party GERB (Citizens for European Development of Bulgaria). Andrey Kovatchev became a Member of the European Parliament after the elections in 2009 form the ticket of PP GERB. Since March 2011 Andrey Kovatchev has been vice-president of the Union of European Federalists. Furthermore he is a Chairman of the Union of the European Federalists in Bulgaria. Since January 2012 he is vice-chairman of AFET – Committee on Foreign Affairs of the European Parliament.
Dr. Andrey Kovatchev is a Member and a vice-chair of the Committee on Foreign Affairs in the European Parliament; he is a member of the Subcommittee on Security and Defence and the Delegation for Relations with the United States; He is a Substitute of the Committee on Regional Development and in the Delegation for Relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN).
European Men's Health Forum
Ian is a retired accident and emergency doctor and general practitioner. He is a former president of the Men’s Health Forum (England and Wales), past vice president of the International Society of Men’s Health (ISMH), past deputy editor of the Men’s Health Journal and for six years the medical editor for Men’s Health magazine. He was a trustee of Developing Patient Partnerships (DPP, formerly Doctor Patient Partnership) for six years. Ian is a founder member of the Self Care Forum (UK) and the official spokesman on men’s health issues for the BMA.
Ian was appointed visiting professor of men’s health in Europe by Leeds Metropolitan University in 2005 and awarded the Royal Society of Public Health (RSPH) Gold Medal for public health in 2007, followed by appointment to the RSPH Academy. In 2012, the RSPH appointed Ian as Professorial Fellow to the Society. The City of Vienna and the ISMH honoured Ian with their award for public health in September 2007. He is now visiting professor in men’s health at the University of Ulster and honorary senior lecturer in men and cancer at Queens University Medical School. He currently chairs the European Cancer Organisation (ECCO) patient advisory committee and the European Forum Against Blindness.
In 2013, Ian was appointed to the board of the European Cancer Concord which produced the Cancer Patient’s Bill of Rights. He acts as the Guardian of the Royal College of General Practitioner’s (RCGP) syllabus and statement on men’s health and is a trustee of the European Pharmaceutical Students’ Association. In January 2015, Ian was appointed Visiting Professor in cancer inequalities at Leeds University and to the European Society of Medical Oncologists’ (ESMO) patient advocacy committee.
Associate Professor, University of Copenhagen, Denmark
Prof. Jesper Holst Pedersen, University of Copenhagen, Denmark, is an associate professor and consultant in thoracic surgery at Copenhagen University Hospital, Rigshospitalet. He is chairman of the surgical subcomittee of the IASLC strategic screening advisory committee. Prof. Peterson advocates for the early detection of patients with lung cancer through CT scans and calls for the EU and its member states to prepare guidelines on screening to ensure adequate follow up and management.
Member of the European Parliament
Sirpa Pietikäinen is a Finnish member of the European People's Party (EPP) in the European parliament. Ms Pietikäinen is former Finnish Minister of Environment (1991–1995). Her career at the Finnish parliament is extensive, ranging from the year 1983 to 2003. She first came to the European parliament to replace Alexander Stubb in 2008, and was re-elected in 2009.
In the European parliament, Ms Pietikäinen is a Member of the Economic and Monetary Affairs Committee and a substitute member of the Women’s Right and Gender Equality Committee and of the Committee on the Environment, Public Health and Food Safety. She is the rapporteur for the circular economy package in the European Parliament. A graduate from the Helsinki School of Economics, Ms Pietikäinen has MSc (Business), and still teaches university courses on negotiations theory and practices.
Ms Pietikäinen has a long track-record in the field of promoting sustainable development. She has actively worked with a number of NGOs promoting environmental issues, democracy, and human rights.
Member of Parliament, Portugal
Ricardo Baptista Leite is an elected Member of Parliament in Portugal. He is also an elected member at Cascais City Hall Parliament, since 9 October 2005 (on his third term). Ricardo is the Head of Public Health at the Catholic University of Portugal. He is a guest lecturer at the NOVA Medical School and NOVA Information Management School, where he is also the coordinator of the curricular unit on Sustainable Healthcare. He is also a medical consultant at a multinational company in the field of information technologies geared to healthcare. He was a PhD candidate in Public Health and Health Systems at Maastricht University (the Netherlands). Ricardo completed his post-graduate studies in many universities in Europe and abroad, among which are Johns Hopkins University (MD, USA), Harvard Medical School (MA, USA), Harvard Kennedy School of Government/IESE (Madrid, Spain), Albert Einstein College of Medicine (NY, USA) and AESE Business School (Lisbon, Portugal). He is also part of the ZEIT Stiftung alumni and Senior Fellow at New Westminster College (British Columbia, Canada). He is the founder of CREATING HEALTH - Research and Innovation Funding. He is a co-founder of the Estoril Conferences. He is a member of the European Leadership Network and of the 2015 European Young Leaders programme. He is the main author of the books Citizenship for Health (Cidadania para a Saúde) and Strategic Consensus for the Integrated Management of Hepatitis C in Portugal (Consenso Estratégico para a Gestão Integrada da Hepatite C em Portugal). He is a public speaker and media commentator on current and economic affairs, health policy, public health, HIV/AIDS, Hepatitis C and other infectious diseases.
Unit of Cancer Epidemiology, Department of Epidemiology Scientific Institute of Public Health, Belgium
Marc Arbyn obtained his MD diploma in 1984 at the University of Ghent (Belgium); he obtained diplomas of Dr in tropical medicine and a MSc degree in tropical epidemiology at the Institute of Tropical Medicine in Antwerp. After a career of 10 years in Africa with Médecins Sans Frontières, he got involved in cancer research in Europe. Marc Arbyn coordinated the evaluation of new screening methods in the framework of the European Network of Cervical Cancer Screening and is editor- of the 2nd edition of European Guidelines for Cervical Cancer Screening (2008). One of his main activities deals with systematic reviews, Cochrane reviews and meta-analyses regarding cervical cancer screening, diagnosis and treatment of screen detected cervical cancer precursors and HPV vaccination. Another point of his interests consists in trend and spatial analysis of cancer incidence and mortality. Over the last two years, MA was author of ~50 papers, published in peer-reviewed journals and a dozen of book chapters.
Deputy Head of Unit for Non Communicable Diseases and the Challenge of Healthy Ageing, European Commission
Karim Berkouk was born in 1970 close to Toulouse in France. He studied Fluid Mechanics at the University of Paul Sabatier (Toulouse, FR) before completing his PhD at the University of Warwick (UK) in bio-fluid mechanics (1999), where he worked on syringomyelia, a rare disease of the spinal cord. He then held various research positions in Exeter (UK), the French National Institute of Health and Medical Research (INSERM, Caen, FR) and the University of Cambridge (UK), where he worked on prosthesis specific to patients, improvement of nuclear brain images and brain connectivity through functional MRI data analysis, respectively.
In 2004, he joined the European Commission to work for the Marie Curie programme first as a project officer and then as a Head of Sector. In November 2011, he joined the Medical Research unit in the Health Directorate as the deputy head of unit to develop and implement research policies on cancer, brain, cardiovascular, chronic diseases, ageing, diabetes and obesity.